Financials
- Market Capitalization 153.7 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-5.59
Fiyat/satışlar oranı
34.34
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3735 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.64 USD | 0.00% | +3.23% | -33.33% | +55.15% | 155.81 M USD | ||
| 3740 | TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.69 USD | -1.43% | -1.43% | -6.76% | -38.39% | 154.72 M USD | ||
| 3748 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.14 USD | -1.72% | -8.06% | -13.64% | -40.00% | 151.90 M USD | ||
| 3751 | EQ Equillium, Inc. - Common Stock | 2.39 USD | -2.45% | +4.37% | +9.13% | +43.11% | 151.55 M USD |